Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CGC

Conservatives Pushing 'Common Good Capitalism' Sound a Lot Like Progressives

The ideology champions the same tired policies that big government types predictably propose whenever they see something they don't like.

Reason

Sell the Farm on These 4 Cannabis Stocks

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

StockNews.com

3 Cannabis Stocks to Avoid Like the Plague in March 2023

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Marijuana Stocks: Buy or Sell These 3 in 2023?

Although several states have legalized marijuana, the industry faces a supply glut amid high inflation impacting overall demand. With Federal legalization unlikely this year, marijuana stocks could remain under pressure. Therefore, would it be wise to invest in marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB)…

StockNews.com

2 Marijuana Stocks to Sell Short, Liquidate or Avoid in 2023

The marijuana industry took a hit facing economic challenges. With no immediate hope of federal legalization, it may be a while until the U.S. government looks favorably toward pot stocks. Hence, fundamentally weak marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) might be best avoided this year. Continue reading….

StockNews.com

4 Marijuana Stocks to Avoid Like the Plague

While marijuana legalization has been rising, the industry is witnessing increased regulations. Moreover, the sector’s revenues have been declining recently. Hence, marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), Sundial Growers (SNDL), and Aurora Cannabis (ACB) might be best avoided, given their weak fundamentals and negative profit margins. Keep reading.

StockNews.com

Acreage Holdings: Analyst Increases Price Target To $1.44 And Remains Neutral

Acreage Holdings, Inc. (OTCQX: ACRDF) reported its financial results on Monday for the third quarter that ended September 30, 2022 (“Q3 2022”).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'

Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray.

Benzinga

2 Marijuana Stocks That Are Nothing Short of Buzzkill

While the cannabis industry might be looking at a possible reversal of fortunes due to increased legalization for recreational and proven medicinal usage, fundamentally weak and beaten-down Marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) may be wealth destroyers. So, it could be wise for investors to avoid these…

StockNews.com

Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception

Canopy Growth Corporation (NASDAQ: CGC)

Benzinga

This Is How It's Done: Why Is Canopy's US Consolidation Plan Blueprint For Other Canadian Cannabis LPs

Canadian cannabis giant Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced its intention to consolidate in the US via a new holding company dubbed Canopy

Benzinga

3 Cannabis Stocks Going up in Flames to Avoid

The wide use of cannabis for recreational activities and its increased medicinal use has helped the market gain traction over the past years. However, with legalization barriers worldwide, this industry is in an odd limbo in which consumption flourishes, but penalties and taxes still prevail. Given the backdrop, it should…

StockNews.com

Canopy Growth Stock Slides, Analysts Divided

Canopy Growth (NASDAQ: CGC) experienced a severe sell-off, as it currently trades at the very bottom of its 52-week range. It's almost near the bottom on shorter time spans, including the 50-day range. The stock is currently down -74.62%, severely underperforming the S&P 500 with a loss of -18.25%.

Benzinga

2Q Canada Recreational Cannabis Market Analysis: +21 YoY Growth Outperforming The U.S.

In a recent analyst note, Cantor Fitzgerald's Pablo Zuanic gave an overview of the Canadian recreational cannabis market in the second quarter of 2022, according to data collected by Hifyre, a leading in-shop and online digital toolset for cannabis dispensaries.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Birmingham Post

Leading Welsh glass manufacturing firm acquired in a multi-million-pound deal

Cwmtillery Glass Centre has been acquired in a deal brokered by Gambit Corporate Finance

StockNews.com

2 Cannabis Stocks to Avoid After Stifel Cuts Their Price Targets

Surging inflation and the Fed’s hawkish monetary policy stance could keep the stock market under pressure in the near term. Amid the uncertainties surrounding the economy and the stock market, Stifel analysts are maintaining a negative outlook on the cannabis industry and have cut their price targets for the stocks…

StockNews.com

Better Buy for 2022: Sundial vs. Canopy Growth

In this article I will analyze and compare Sundial Growers (SNDL) and Canopy Growth (CGC) to determine which cannabis stock is currently the better investment.

Benzinga

What Are Whales Doing With Canopy Growth

A whale with a lot of money to spend has taken a noticeably bearish stance on Canopy Growth. Looking at options history for Canopy Growth (NASDAQ:CGC) we detected 32 strange trades.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What's Going On With Tilray, Canopy Growth And Aurora Cannabis Shares Today?

Tilray Brands Inc (NASDAQ: TLRY), Canopy Growth Corp (NASDAQ: CGC) and Aurora Cannabis Inc (NASDAQ: ACB) are trading lower

Benzinga

Canopy Growth Whale Trades For March 28

Someone with a lot of money to spend has taken a bearish stance on Canopy Growth (NASDAQ:CGC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

StockNews.com

3 Cannabis Stocks To Short Now After Getting Too High

Selling defined risk bear call spreads to get paid now to be a seller at higher prices later.

Benzinga

Why Tilray, Canopy Growth Look Set For New Highs Despite Failing To Hold After-Hours Surge

Canopy Growth Corporation (NASDAQ: CGC) and Tilray, Inc (NASDAQ: TLRY) gapped up slightly higher on Wednesday after running up to 7.43% and 12.87%, respectively, in the after-hours trading session on Tuesday.

Benzinga

Canopy Growth's David Klein And Wana Brands' Nancy Whiteman To Keynote At Benzinga Cannabis Capital Conference

David Klein, CEO of Canopy Growth Corporation (TSX: WEED) NASDAQ: CGC)

Benzinga

Analyst Ratings For Canopy Gwth

Over the past 3 months, 5 analysts have published their opinion on Canopy Gwth (NASDAQ:CGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

StockNews.com

Is Canopy Growth a Smart Cannabis Stock to Own in 2022?

Shares of smart cannabis company Canopy Growth (CGC) have retreated in price significantly over the past few months. However, given that the company recently launched new products across its brand portfolio, is it worth betting on the stock now? Read on, let's find out.

1 2 3

People

Kritika SarmahHer

727 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical – Pharmaceuticals

Canopy Growth Corporation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.